Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

A rigorous evaluation of optimal peptide targets for MS-based clinical diagnostics of Coronavirus Disease 2019 (COVID-19)

Clinical Proteomics(2021)10.1186/s12014-021-09321-1Source: DataRank Database

A rigorous evaluation of optimal peptide targets for MS-based clinical diagnostics of Coronavirus Disease 2019 (COVID-19) is a research paper published in Clinical Proteomics (2021). On theSindex it has a DataRank of 0. It has been cited 10 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access10 citations

Download PDF

Cite:

Linked data & code

pxd doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (8 grants)Impact (FWCI 0.60)OA: goldTopics (24)IDs (PubMed, PMC, OpenAlex)Annotations (2)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (8)

Subina Mehta ORCID,Dinh Duy An Nguyen,Björn Grüning ORCID,James E. Johnson ORCID,Thomas McGowan ORCID

Live enrichment

PubMed:33971807 PMC:PMC8107781 OpenAlex:https://openalex.org/W3163594751

National Cancer Institute

Grant: 1U24CA199347

National Institute of General Medical Sciences

Grant: T32GM008347

Bundesministerium für Bildung und Forschung

Grant: 031 A538A/A538C RBC

Bundesministerium für Bildung und Forschung

Grant: 031L0101B/031L0101C de.NBI-epi

Bundesministerium für Bildung und Forschung

Grant: 031L0106 de.STAIR (de.NBI)

Deutsche Forschungsgemeinschaft

Grant: SFB 992/1 2012

NCI NIH HHS

Grant: UG3 CA244687

NCI NIH HHS

Grant: U24 CA199347

FWCI

0.60

Citation Percentile

0.6%

Citation Trend

2021

2022

2023

2024

2025

goldLicense: cc-by

journalhttps://clinicalproteomicsjournal.biomedcentral.com/counter/pdf/10.1186/s12014-021-09321-1

publisherhttps://clinicalproteomicsjournal.biomedcentral.com/counter/pdf/10.1186/s12014-021-09321-1

publisherhttps://link.springer.com/content/pdf/10.1186/s12014-021-09321-1.pdf

publisherhttps://link.springer.com/article/10.1186/s12014-021-09321-1/fulltext.html

journalhttps://doi.org/10.1186/s12014-021-09321-1

Fields of Study

vaccines and immunoinformatics approachesAdvanced Proteomics Techniques and ApplicationsSARS-CoV-2 and COVID-19 Research

Keywords

Coronavirus disease 2019 (COVID-19)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)2019-20 coronavirus outbreakCoronavirusCoronavirus InfectionsDiseaseVirologyProteomicsPandemicMedicineBetacoronavirusComputational biologyBioinformaticsBiologyInfectious disease (medical specialty)Internal medicineOutbreakMass spectrometryWorkflowsViral ProteomePeptide-detection

Sustainable Development Goals

SDG 0: Good health and well-being

A rigorous evaluation of optimal peptide targets for MS-based clinical diagnostics of Coronavirus Disease 2019 (COVID-19)

FAIR Checklist

Authors (8)

Funding (8 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)